Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
British Journal of Cancer|November 23, 2023
Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trialHans-Joachim Schmoll, Julia Mann, Fabian Meinert, et al.Cancer Medicine|June 14, 2021
Preinfection laboratory parameters may predict COVID-19 severity in tumor patientsAlexander Kiani, Romina Roesch, Clemens M Wendtner, et al.Leukemia|March 6, 2024
Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registriesJohannes Lübke, Deborah Christen, Juliana Schwaab, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2002
Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphomaUlrich Kaiser, Irmgard Uebelacker, Ulrich Abel, et al.Molecular Oncology|October 5, 2024
Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patientsNataša Stojanović Gužvić, Florian Lüke, Steffi Treitschke, et al.Journal of Cancer Research and Clinical Oncology|September 28, 2022
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registryMaher Hanoun, Leo Ruhnke, Michael Kramer, et al.Cancers|September 27, 2025
Prognostic Role of Kidney Disease in Newly Diagnosed Acute Myeloid Leukemia Under Venetoclax-Based Low-Intensity TherapyKatja Krüger, Razif Gabdoulline, Martin Wichmann, et al.British Journal of Cancer|August 4, 2023
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experienceJulius C Enßle, Sebastian Wolf, Sebastian Scheich, et al.Blood Cancer Journal|May 26, 2023
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcomeJulia-Annabell Georgi, Sebastian Stasik, Jan-Niklas Eckardt, et al.Cancers|October 27, 2022
Identification of Disparities in Personalized Cancer Care-A Joint Approach of the German WERA ConsortiumFlorian Lüke, Florian Haller, Kirsten Utpatel, et al.Pageof 7